12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Oncolytics preclinical data

In a mouse model of melanoma, paclitaxel for 3 consecutive days followed by 2 daily IV injections of Reolysin repeated for 3 weeks significantly improved survival compared to all other treatment groups...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >